Infinium Pharmachem Limited (NSE:INFINIUM)
217.00
+0.10 (0.05%)
At close: Mar 6, 2026
Infinium Pharmachem Market Cap
Infinium Pharmachem has a market cap or net worth of 3.38 billion as of March 6, 2026. Its market cap has decreased by -17.91% in one year.
Market Cap
3.38B
Enterprise Value
3.59B
Revenue
1.57B
Ranking
n/a
PE Ratio
35.77
Stock Price
217.00
Market Cap Chart
Since April 17, 2023, Infinium Pharmachem's market cap has increased from 1.03B to 3.38B, an increase of 228.81%. That is a compound annual growth rate of 51.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 3.38B | -2.69% |
| Dec 31, 2025 | 3.47B | -16.77% |
| Dec 31, 2024 | 4.17B | 27.62% |
| Dec 29, 2023 | 3.27B | 218.00% |
| Apr 17, 2023 | 1.03B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Accent Microcell | 7.27B |
| Remus Pharmaceuticals | 7.08B |
| Quest Laboratories | 1.88B |
| Sotac Pharmaceuticals | 1.23B |
| Zenith Drugs | 840.29M |
| Vilin Bio Med | 481.28M |
| Medicamen Organics | 266.76M |
| Sunrest Lifescience | 193.10M |